SWITCH THERAPEUTICS

In News

Former CDC Director Robert Redfield Joins Turn Therapeutics as Chief Scientific Officer - Dermatology Times

Dermatology Times - Sep 09, 2026

Stoke Therapeutics Auditor Switch Puts Biotech Governance In Focus - Yahoo Finance

Yahoo Finance - Apr 06, 2026

Now or later? Switching therapies in metastatic breast cancer - The Lancet

The Lancet - Jul 14, 2026

Sangamo looks to switch lenders midbankruptcy as it eyes a quick sale process - The Business Journals

The Business Journals - Jul 22, 2026

Sanofi’s stunning CEO switch—Chutes & Ladders - Fierce Biotech

Fierce Biotech - Feb 13, 2026

Gene therapy ‘switch’ may offer non-addictive pain relief - Penn Medicine

Penn Medicine - Jan 07, 2026

Turn Therapeutics Insiders May Regret Not Buying More, Market Cap Hits US$217m - simplywall.st

simplywall.st - Jul 01, 2026

Targeting the ApoE4 Gene to Treat Alzheimer’s - Being Patient

Being Patient - Apr 07, 2026

A New CRISPR "DNA Shredder" Could Change Gene-Editing -- What It Means for CRISPR Therapeutics - fool.com

fool.com - Jul 08, 2026

Dual switches ignite tumour-specific mRNA therapeutics - Nature

Nature - Nov 12, 2025

Cancer – Switch Receptors to Advance Immunotherapy - seattlechildrens.org

seattlechildrens.org - Apr 10, 2026

Journal of the European Academy of Dermatology and Venereology - Wiley Online Library

Wiley Online Library - Nov 08, 2025

Stay Informed

Join our mailing list for the latest report releases and upcoming event notifications.

Headquartered in Boston, Mass., for over 50 years, BCC Research takes pride in being your trusted custom research and data analysts. Our mission is to provide businesses with reputable data and market research reports, so that they gain new perspectives into their field and better understand their target audience. We enable companies to access reliable information, accurate forecasts, and actionable insights, so that they may become leaders in their industry.

AI Sentiment